About

Andrea Marmiroli is a leading researcher in urologic oncology, specializing in the comparative effectiveness and health economics of robotic versus open surgery for major genitourinary cancers. Her work centers on quantifying real-world outcomes—including in-hospital complications, survival, and total hospital costs—for procedures such as radical nephroureterectomy, radical cystectomy, partial nephrectomy, and radical prostatectomy. Marmiroli’s landmark studies, drawing on large national databases like the National Inpatient Sample, have provided critical evidence that robot-assisted approaches can reduce adverse in-hospital events and, in some cases, lower total hospital costs compared to open surgery. Her most cited paper (16 citations) examines in-hospital outcomes after robotic vs. open nephroureterectomy, while her cost-analysis studies (14 and 8 citations) have directly informed surgical decision-making and healthcare policy. She has also pioneered investigations into outcomes for specific patient populations, including quadragenarians and octogenarians undergoing radical prostatectomy and cystectomy. With over 70 total citations across her recent publications, Marmiroli’s work is instrumental in shaping evidence-based guidelines for minimally invasive urologic surgery.

Research Focus

Key Achievements

5
H-Index
9
Papers
72
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
In-Hospital Outcomes after Robotic <i>Vs</i> Open Radical Nephroureterectomy
16 citations · 2025
📈 Most Prolific Year: 2025 (8 Papers)
🤝 Key Collaborators: 54
🏛 Institutions: University of Milan, European Institute of Oncology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Istituti di Ricovero e Cura a Carattere Scientifico

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago